©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Zelira Therapeutics
Zelira secures US$8.6 million cornerstone funding for FDA clinical trials for HOPE-1(R) Cannabinoid Medicine...
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the development and commercialization of clinically validated cannabinoid-based medicines, is delighted to announce that it...